Carbazole compounds, mixtures, compositions and organic electronic devices

By using carbazole compounds in OLED, the introduction of nitrogen-containing electron-absorbing groups and non-conjugated five-membered ring structures is solved, and the luminous efficiency and life of the device are improved.

CN115925691BActive Publication Date: 2024-12-06GUANGZHOU CHINARAY OPTOELECTRONICS MATERIALS LTD
View PDF 6 Cites 0 Cited by

Patent Information

Application Number
CN202111157687.6
Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
Filing Date
2021-09-30
Publication Date
2024-12-06
Estimated Expiration
2041-09-30

AI Technical Summary

Technical Problem

In high-brightness applications, existing organic light emitting diodes (OLEDs) have the problem that the luminous efficiency decreases with the increase of current or brightness, and in traditional material designs, there is still room for improvement in the luminous efficiency and life of the main material that transmits bipolarly in traditional material designs.

Method used

Carbazole compounds are used as the main material, and the hole and electron transport capability of the compound is enhanced by introducing nitrogen-containing electron-absorbing groups and non-conjugated five-membered ring structures, and the exciton utilization rate and device stability are improved.

Benefits of technology

It significantly improves the luminous efficiency and service life of OLED devices, and achieves higher internal electroluminescent quantum efficiency and stability.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN115925691B_ABST
    Figure CN115925691B_ABST
Patent Text Reader

Abstract

The present invention provides a carbazole compound, a mixture, a composition and an organic electronic device. The structure of the carbazole compound is shown in the general formula (1), and the carbazole compound can be used as a main material in the functional layer of an electronic device to improve the efficiency and life of the device.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention relates to the field of organic electroluminescence, and in particular to a carbazole compound, a mixture, a composition and an organic electronic device. Background Art

[0002] Organic semiconductor materials have diversity in synthesis, relatively low manufacturing costs and excellent optical and electrical properties. Organic light-emitting diodes (OLEDs) have broad development potential in optoelectronic devices (such as flat-panel displays and lighting) due to their wide viewing angle, fast response time, low operating voltage and thin panel thickness.

[0003] In order to improve the luminous efficiency of organic light-emitting diodes, various fluorescent and phosphorescent luminescent material systems have been developed. Among them, organic light-emitting diodes using fluorescent materials have the characteristics of high reliability, but their internal electroluminescence quantum efficiency is limited to 25% under electrical excitation, because the branching ratio of the singlet excited state and triplet excited state of the exciton is 1:3. Organic light-emitting diodes using phosphorescent materials have achieved an internal electroluminescence quantum efficiency of almost 100%, but phosphorescent OLEDs have a major difficulty: the Roll-off effect, that is, the luminous efficiency decreases rapidly with the increase of current or brightness, which is particularly unfavorable for high-brightness applications.

[0004] The luminescent material (guest) can be used together with the matrix material (host) as a luminescent material to improve color purity, luminous efficiency and stability. Since the host material has a great influence on the efficiency and characteristics of the electroluminescent device when the host material / guest system is used as the luminescent layer of the light-emitting device, the selection of the host material is very important.

[0005] At present, 4,4'-dicarbazole-biphenyl (CBP) is the most widely known matrix material for phosphorescent materials. In recent years, Pioneer Corporation of Japan has developed a high-performance organic electroluminescent device that uses compounds such as BAlq (bis(2-methyl)-8-hydroxyquinoline-4-phenylphenol aluminum (III)) and phenanthroline (BCP) as matrices. In traditional material design, it is usually preferred to use a combination of electron transport groups and hole transport groups to design a bipolar transport host, which is beneficial to the balance of charge transfer. Using bipolar transport molecules as the host can obtain good device performance, but the luminous efficiency and life of the obtained device still need to be improved. Summary of the invention

[0006] Based on this, the present invention provides a carbazole compound, which can be used as a main material in a functional layer of an electronic device to extend the luminous efficiency and service life of the device.

[0007] The present invention is achieved through the following technical solutions:

[0008] A carbazole compound, the structure of which is shown in the general formula (1):

[0009]

[0010] in:

[0011] A is selected from a substituted or unsubstituted aromatic group having 6 to 20 ring atoms, or a substituted or unsubstituted heteroaromatic group having 5 to 20 ring atoms;

[0012] L1 is selected from a single bond, a substituted or unsubstituted aromatic group having 6 to 40 ring atoms, or a substituted or unsubstituted heteroaromatic group having 5 to 40 ring atoms;

[0013] Ar is selected from any one of the structures (A-1) to (A-3):

[0014]

[0015] Ar1, Ar2, Ar3 are independently selected from: a substituted or unsubstituted aromatic group having 6 to 40 ring atoms, or a substituted or unsubstituted heteroaromatic group having 5 to 40 ring atoms;

[0016] E1 is selected from a substituted or unsubstituted aromatic group having 6 to 20 ring atoms, or a substituted or unsubstituted heteroaromatic group having 5 to 20 ring atoms;

[0017] Each occurrence of Z1 is independently selected from CR1 or N, and at least one Z1 is selected from N;

[0018] R1 is independently selected at each occurrence from: -H, -D, linear alkyl having 1 to 20 C atoms, linear alkoxy having 1 to 20 C atoms, linear thioalkoxy having 1 to 20 C atoms, branched or cyclic alkyl having 3 to 20 C atoms, branched or cyclic alkoxy having 3 to 20 C atoms, branched or cyclic thioalkoxy having 3 to 20 C atoms, silyl, -CN, -CF3, -Cl, -Br, -F, -I, substituted or unsubstituted aromatic radical having 6 to 60 ring atoms, substituted or unsubstituted heteroaromatic radical having 5 to 60 ring atoms, aryloxy having 6 to 60 ring atoms, heteroaryloxy having 5 to 60 ring atoms, or a combination of these radicals;

[0019] * indicates the attachment site.

[0020] The present invention also provides a mixture, which comprises the carbazole compound as described above and at least one organic functional material, wherein the organic functional material is selected from hole injection materials, hole transport materials, electron transport materials, electron injection materials, electron blocking materials, hole blocking materials, luminophores or host materials.

[0021] The present invention also provides a composition, which comprises the carbazole compound or the mixture as described above, and at least one organic solvent.

[0022] The present invention also provides an organic electronic device, which comprises the carbazole compound as described above, the mixture as described above, or is prepared from the composition as described above.

[0023] Compared with the prior art, the carbazole compounds of the present invention have the following beneficial effects:

[0024] The carbazole compound of the present invention adopts the structure of carbazole derivative-nitrogen-containing electron-withdrawing group, and introduces Group, The group has a non-completely conjugated five-membered ring structure, and the carbazole group is a conjugated group. Through the intermolecular interaction between the non-conjugated group and the conjugated group, the hole transport property of the carbazole derivative is brought into play; the nitrogen-containing electron-withdrawing group has an electron transport property, and can realize the bipolar carrier transport ability of the compound in combination with the carbazole derivative; the above characteristics of the carbazole compound described in the present invention are conducive to improving the exciton utilization rate and device stability of the OLED device using the compound of the present invention as the main material, thereby achieving the purpose of improving the luminous efficiency and life of the device. DETAILED DESCRIPTION

[0025] For ease of understanding of the present invention, the present invention will be described more fully below with reference to relevant embodiments. Preferred embodiments of the present invention are provided in the embodiments. However, the present invention can be implemented in many different forms and is not limited to the embodiments described herein. On the contrary, the purpose of providing these embodiments is to make the understanding of the disclosure of the present invention more thorough and comprehensive.

[0026] Unless otherwise defined, all technical and scientific terms used herein have the same meaning as those commonly understood by those skilled in the art of the present invention. The terms used herein in the specification of the present invention are only for the purpose of describing specific embodiments and are not intended to limit the present invention. The term "and / or" used herein includes any and all combinations of one or more related listed items.

[0027] In the present invention, composition and printing ink, or ink have the same meaning and can be interchanged.

[0028] In the present invention, aromatic group, aromatic series and aromatic ring system have the same meaning and can be interchanged.

[0029] In the present invention, heteroaromatic group, heteroaromatic series and heteroaromatic ring system have the same meaning and can be interchanged.

[0030] In the present invention, "substituted" means that a hydrogen atom in a substituted group is replaced by a substituent.

[0031] In the present invention, when the same substituent appears multiple times, it can be independently selected from different groups. If the general formula contains multiple R1, then R1 can be independently selected from different groups.

[0032] In the present invention, "substituted or unsubstituted" means that the defined group may be substituted or unsubstituted. When the defined group is substituted, it should be understood that the defined group may be substituted by one or more substituents R, wherein R is selected from but not limited to: deuterium atom (D), cyano, isocyano, nitro or halogen, alkyl containing 1-20 C atoms, heterocyclic group containing 3-20 ring atoms, aromatic group containing 6-20 ring atoms, heteroaromatic group containing 5-20 ring atoms, -NR'R", silane, carbonyl, alkoxycarbonyl, aryloxycarbonyl, carbamoyl, haloformyl, formyl, isocyanate, thiocyanate, isothiocyanate, hydroxyl, trifluoromethyl, and the above groups may be further substituted by substituents acceptable in the art; it is understandable that R' and R" in -NR'R" are independently selected from but not limited to: H, deuterium, thiocyanate, isothiocyanate, hydroxyl, trifluoromethyl. Atom, cyano group, isocyano group, nitro group or halogen group, alkyl group containing 1-10 C atoms, heterocyclic group containing 3-20 ring atoms, aromatic group containing 6-20 ring atoms, heteroaromatic group containing 5-20 ring atoms. Preferably, R is selected from but not limited to: deuterium atom, cyano group, isocyano group, nitro group or halogen group, alkyl group containing 1-10 C atoms, heterocyclic group containing 3-10 ring atoms, aromatic group containing 6-20 ring atoms, heteroaromatic group containing 5-20 ring atoms, silane group, carbonyl group, alkoxycarbonyl group, aryloxycarbonyl group, carbamoyl group, haloformyl group, formyl group, isocyanate group, thiocyanate group, isothiocyanate group, hydroxyl group, trifluoromethyl group, and the above groups can also be further substituted by substituents acceptable in the art.

[0033] In the present invention, the "number of ring atoms" refers to the number of atoms in the atoms constituting the ring itself of a structural compound (e.g., a monocyclic compound, a condensed ring compound, a cross-linked compound, a carbocyclic compound, a heterocyclic compound) in which atoms are bonded to form a ring. When the ring is substituted with a substituent, the atoms contained in the substituent are not included in the ring atoms. The same is true for the "number of ring atoms" described below unless otherwise specified. For example, the number of ring atoms of a benzene ring is 6, the number of ring atoms of a naphthalene ring is 10, and the number of ring atoms of a thienyl group is 5.

[0034] "Aryl or aromatic group" refers to an aromatic hydrocarbon group derived from an aromatic ring compound by removing a hydrogen atom, which can be a monocyclic aromatic group, a condensed aromatic group, or a polycyclic aromatic group. For polycyclic rings, at least one is an aromatic ring system. For example, "substituted or unsubstituted aromatic group having 6 to 40 ring atoms" refers to an aromatic group containing 6 to 40 ring atoms, preferably a substituted or unsubstituted aromatic group having 6 to 30 ring atoms, more preferably a substituted or unsubstituted aromatic group having 6 to 18 ring atoms, and particularly preferably a substituted or unsubstituted aromatic group having 6 to 14 ring atoms, and the aromatic group is optionally further substituted; suitable examples include, but are not limited to: phenyl, biphenyl, terphenyl, naphthyl, anthracenyl, phenanthrenyl, fluoranthenyl, triphenylene, pyrenyl, perylene, naphthyl, fluorenyl, dinaphthylenyl, acenaphthene and derivatives thereof. It is understandable that multiple aromatic groups may also be interrupted by short non-aromatic units (e.g. <10% non-H atoms, such as C, N or O atoms), specifically acenaphthene, fluorene, or 9,9-diarylfluorene, triarylamine, diaryl ether systems should also be included in the definition of aromatic groups.

[0035] "Heteroaryl or heteroaromatic group" means that at least one carbon atom is replaced by a non-carbon atom on the basis of an aryl group, and the non-carbon atom can be an N atom, an O atom, an S atom, etc. For example, "substituted or unsubstituted heteroaryl having 5 to 40 ring atoms" means a heteroaryl having 5 to 40 ring atoms, preferably a substituted or unsubstituted heteroaryl having 6 to 30 ring atoms, more preferably a substituted or unsubstituted heteroaryl having 6 to 18 ring atoms, and particularly preferably a substituted or unsubstituted heteroaryl having 6 to 14 ring atoms, and the heteroaryl group is optionally further substituted, and suitable examples include but are not limited to: thienyl, furanyl, pyrrolyl, imidazolyl, triazolyl, imidazolyl, oxadiazolyl, triazolyl, pyridyl, bipyridyl, pyrimidyl, triazinyl, triazolyl, acridinyl, pyridazinyl, pyridinyl, oxazine, quinolyl, quinazolinyl, quinoxalinyl, phthalazinyl, pyridopyrimidinyl, pyridopyrazinyl, pyrazinopyrazinyl, isoquinolyl, indolyl, carbazolyl, benzothiophenyl, benzofuranyl, indolyl, carbazolyl, pyrroloimidazolyl, pyrrolopyrrolyl, thienopyrrolyl, thienothiphenyl, furopyrrolyl, furofuranyl, thienofuranyl, benzisoxazolyl, benzisothiazolyl, benzimidazolyl, quinolyl, isoquinolyl, o-naphthyl, quinoxalinyl, phenanthridinyl, primary pyridyl, quinazolinyl, quinazolinone, dibenzothiophenyl, dibenzofuranyl, carbazolyl and derivatives thereof.

[0036] In the present invention, "alkyl" may refer to a linear, branched and / or cyclic alkyl group. The carbon number of the alkyl group may be 1 to 50, 1 to 30, 1 to 20, 1 to 10 or 1 to 6. Phrases containing this term, such as "C 1-9The term "alkyl" refers to an alkyl group containing 1 to 9 carbon atoms, and each occurrence may be independently C1 alkyl, C2 alkyl, C3 alkyl, C4 alkyl, C5 alkyl, C6 alkyl, C7 alkyl, C8 alkyl or C9 alkyl. Non-limiting examples of alkyl groups include methyl, ethyl, n-propyl, isopropyl, n-butyl, sec-butyl, tert-butyl, isobutyl, 2-ethylbutyl, 3,3-dimethylbutyl, n-pentyl, isopentyl, neopentyl, tert-butyl, 2-ethyl ... pentyl, cyclopentyl, 1-methylpentyl, 3-methylpentyl, 2-ethylpentyl, 4-methyl-2-pentyl, n-hexyl, 1-methylhexyl, 2-ethylhexyl, 2-butylhexyl, cyclohexyl, 4-methylcyclohexyl, 4-tert-butylcyclohexyl, n-heptyl, 1-methylheptyl, 2,2-dimethylheptyl, 2-ethylheptyl, 2-butylheptyl, n-octyl, tert-octyl, 2-ethyloctyl, 2-butyloctyl, 2-hexyloctyl, 3,7-dimethyloctyl, cyclooctyl, n-nonyl, n-decyl, adamantyl, 2-ethyldecyl, 2-butyldecyl, 2-hexyldecyl, 2-octyldecyl, n-undecyl, n-dodecyl, 2-ethyldodecyl, 2-butyldodecyl, 2-hexyldodecyl, 2-octyldodecyl, n-tridecyl, n-tetradecyl, n-pentadecyl, n-hexadecyl, 2-ethylhexadecyl, 2-butylhexadecyl, 2-hexylhexadecyl, 2-octylhexadecyl, n-heptadecyl, n-octadecyl, n-nonadecyl, n-eicosyl, 2-ethyleicosyl, 2-butyleicosyl, 2-hexyleicosyl, 2-octyleicosyl, n-heneicosyl, n-docosyl, n-tricosyl, n-tetracosyl, n-pentacosyl, n-hexacosyl, n-heptacosyl, n-octacosyl, n-nonacosyl, n-triacontyl, adamantane, and the like.

[0037] In the present invention, the substituent abbreviations correspond to: n-normal, sec-secondary, i-iso, t-tertiary, o-ortho, m-meta, p-para, Me methyl, Et ethyl, Pr propyl, Bu butyl, Am n-pentyl, Hx hexyl, Cy cyclohexyl.

[0038] "Amine" refers to an amine derivative having the structural features of the formula -N(X)2, wherein each "X" is independently H, substituted or unsubstituted alkyl, substituted or unsubstituted cycloalkyl, substituted or unsubstituted heterocyclyl, etc. Non-limiting types of amines include -NH2, -N(alkyl)2, -NH(alkyl), -N(cycloalkyl)2, -NH(cycloalkyl), -N(heterocyclyl), -NH(heterocyclyl), -N(aryl), -NH(aryl), -N(alkyl)(aryl), -N(alkyl)(heterocyclyl), -N(cycloalkyl)(heterocyclyl), -N(aryl)(heteroaryl), -N(alkyl)(heteroaryl), etc.

[0039] In the present invention, "*" connected to a single bond indicates a connection or fusion site;

[0040] In the present invention, when a linking site is not specified in a group, it means that any linking site in the group can be used as a linking site;

[0041] In the present invention, when the fusion site is not specified in the group, it means that any fusion site in the group can be used as the fusion site, and preferably two or more sites in the ortho position in the group are fusion sites;

[0042] In the present invention, when a group contains multiple substituents with the same symbol, the substituents may be the same or different from each other. 6 R on the benzene ring 1 May be the same as or different from each other.

[0043] In the present invention, the single bond to which the substituent is connected runs through the corresponding ring, indicating that the substituent can be connected to any position of the ring, for example In which R is connected to any substitutable position of the benzene ring, such as express Can be used with The above optional substitutable positions form a ring.

[0044] In the present invention, "adjacent groups" means that there is no substitutable site between two substituents.

[0045] According to the present invention, the cyclic alkyl or cycloalkyl group has the same meaning and can be interchanged.

[0046] The present invention provides a carbazole compound, the structure of which is shown in the general formula (1):

[0047]

[0048] in:

[0049] A is selected from a substituted or unsubstituted aromatic group having 6 to 20 ring atoms, or a substituted or unsubstituted heteroaromatic group having 5 to 20 ring atoms;

[0050] L1 is selected from a single bond, a substituted or unsubstituted aromatic group having 6 to 40 ring atoms, or a substituted or unsubstituted heteroaromatic group having 5 to 40 ring atoms;

[0051] Ar is selected from any one of the structures (A-1) to (A-3):

[0052]

[0053] Ar1, Ar2, Ar3 are independently selected from: a substituted or unsubstituted aromatic group having 6 to 40 ring atoms or a substituted or unsubstituted heteroaromatic group having 5 to 40 ring atoms;

[0054] E1 is selected from a substituted or unsubstituted aromatic group having 6 to 20 ring atoms or a substituted or unsubstituted heteroaromatic group having 5 to 20 ring atoms;

[0055] Each occurrence of Z1 is independently selected from CR1 or N, and at least one Z1 is selected from N;

[0056] R1 is independently selected at each occurrence from: -H, -D, linear alkyl having 1 to 20 C atoms, linear alkoxy having 1 to 20 C atoms, linear thioalkoxy having 1 to 20 C atoms, branched or cyclic alkyl having 3 to 20 C atoms, branched or cyclic alkoxy having 3 to 20 C atoms, branched or cyclic thioalkoxy having 3 to 20 C atoms, silyl, -CN, -CF3, -Cl, -Br, -F, -I, substituted or unsubstituted aromatic radical having 6 to 60 ring atoms, substituted or unsubstituted heteroaromatic radical having 5 to 60 ring atoms, aryloxy having 6 to 60 ring atoms, heteroaryloxy having 5 to 60 ring atoms, or a combination of these radicals;

[0057] * indicates the attachment site.

[0058] In a specific example, the substitution or unsubstitution described in the present invention refers to being substituted or unsubstituted by one or more substituents R, wherein the substituent R has the same meaning as described above. Preferably, the substituent R is selected from an alkyl group having 1-10 C atoms, an aryl group having 6-20 ring atoms, or a heteroaryl group having 5-20 ring atoms; further, the substituent R is selected from an alkyl group having 1-8 C atoms, an aryl group having 6-10 ring atoms, or a heteroaryl group having 6-13 ring atoms.

[0059] In a specific example, the structure of the carbazole compound is selected from any one of the structures shown in general formulas (2-1) to (2-4):

[0060]

[0061] In a specific example, A is selected from a substituted or unsubstituted aromatic group having 6 to 18 ring atoms or a substituted or unsubstituted heteroaromatic group having 6 to 18 ring atoms;

[0062] Furthermore, A is selected from the group shown in any one of (B-1) to (B-6):

[0063]

[0064] in:

[0065] Ar4 is selected from a substituted or unsubstituted aromatic group having 6 to 13 ring atoms, a substituted or unsubstituted heteroaromatic group having 6 to 13 ring atoms;

[0066] Each occurrence of X1 is independently selected from N or CR3;

[0067] Y1 is selected from O, S, S=O, SO2, NR4, PR4, CR5R6 or SiR5R6;

[0068] R3, R4, R5, R6 are each independently selected from: -H, -D, straight-chain alkyl with 1 to 20 C atoms, straight-chain alkoxy with 1 to 20 C atoms, straight-chain thioalkoxy with 1 to 20 C atoms, branched or cyclic alkyl with 3 to 20 C atoms, branched or cyclic alkoxy with 3 to 20 C atoms, branched or cyclic thioalkoxy with 3 to 20 C atoms, substituted or unsubstituted silyl, keto with 1 to 20 C atoms, 2 to 20 C atoms, 3 to 20 C atoms, 4 to 6 carbon atoms, 5 to 8 carbon atoms, 6 to 8 carbon atoms, 7 to 8 carbon atoms, 8 to 9 carbon atoms, 9 to 10 carbon atoms, 10 to 11 carbon atoms, 12 to 13 carbon atoms, 14 to 15 carbon atoms, 15 to 16 carbon atoms, 16 to 17 carbon atoms, 17 to 18 carbon atoms, 18 to 19 carbon atoms, 19 to 20 carbon atoms, 19 to 21 carbon atoms, 19 to 22 carbon atoms, 19 to 23 carbon atoms, 19 to 24 carbon atoms, 19 to 25 carbon atoms, 19 to 2 substituted or unsubstituted aryloxy having 6 to 13 ring atoms, substituted or unsubstituted heteroaromatic having 5 to 13 ring atoms, substituted or unsubstituted aryloxy having 6 to 13 ring atoms, heteroaryloxy having 5 to 13 ring atoms, or a combination of these groups;

[0069] R5 and R6 may or may not form a ring with each other.

[0070] It can be understood that in the present invention, when X1 is a linking site, X1 is C.

[0071] Preferably, each occurrence of R3, R4, R5, R6 is independently selected from -H, -D, or a linear alkyl group having 1 to 10 C atoms, or a branched or cyclic alkyl group having 3 to 10 C atoms, or a phenyl group, or a naphthyl group.

[0072] In one embodiment, each occurrence of R3 is independently selected from -H, -D, or a linear alkyl group having 1 to 10 C atoms, or a branched or cyclic alkyl group having 3 to 10 C atoms.

[0073] Further, Ar4 is selected from Wherein: X1 and Y1 have the same meanings as above.

[0074] In a specific example, A is selected from any of the following groups:

[0075]

[0076] Where: * indicates a connection or fusion site.

[0077] Preferably, X1 is selected from CR3, and R3 has the same meaning as above.

[0078] In one embodiment, the structure of the carbazole compound is selected from any one of the structures shown in general formulas (3-1) to (3-16):

[0079]

[0080]

[0081] It can be understood that the general formula (3-2) is selected from the structure shown in any one of formulas (4-1) to (4-3):

[0082]

[0083] It can be understood that the general formula (3-3) is selected from the structure shown in any one of formulas (4-4) to (4-9):

[0084]

[0085]

[0086] In a specific example, L1 is selected from a single bond, or a substituted or unsubstituted aromatic group having 6 to 18 ring atoms, or a substituted or unsubstituted heteroaromatic group having 5 to 18 ring atoms.

[0087] In a specific example, L1 is selected from a single bond or a group as shown below:

[0088]

[0089] in:

[0090] Each occurrence of X2 is independently selected from N or CR7;

[0091] Y2 is selected from O, S, S=O, SO2, NR8, PR8, CR8R9 or SiR8R9;

[0092] R7, R8, and R9 are each independently selected from: -H, -D, straight-chain alkyl having 1 to 20 C atoms, straight-chain alkoxy having 1 to 20 C atoms, straight-chain thioalkoxy having 1 to 20 C atoms, branched or cyclic alkyl having 3 to 20 C atoms, branched or cyclic alkoxy having 3 to 20 C atoms, branched or cyclic thioalkoxy having 3 to 20 C atoms, substituted or unsubstituted silyl, keto having 1 to 20 C atoms, Alkoxycarbonyl, aryloxycarbonyl having 7 to 20 C atoms, cyano, carbamoyl, haloformyl, formyl, isocyano, isocyanate, thiocyanate, isothiocyanate, hydroxy, nitro, -CF3, -Cl, -Br, -F, substituted or unsubstituted aromatic radicals having 6 to 20 ring atoms, substituted or unsubstituted heteroaromatic radicals having 5 to 20 ring atoms, substituted or unsubstituted aryloxy radicals having 6 to 20 ring atoms, heteroaryloxy radicals having 5 to 20 ring atoms, or combinations of these radicals.

[0093] It can be understood that in the present invention, when X2 is a linking site, X2 is C.

[0094] Further, L1 is selected from a single bond, a substituted or unsubstituted phenyl group, a substituted or unsubstituted biphenyl group, a substituted or unsubstituted terphenyl group, a substituted or unsubstituted naphthyl group, a substituted or unsubstituted phenanthrenyl group, a substituted or unsubstituted 9,9-fluorenyl group, a substituted or unsubstituted dibenzofuranyl group, a substituted or unsubstituted dibenzothiophenyl group, a substituted or substituted carbazolyl group, or a substituted or unsubstituted 9-carbazolyl group; further, the substituent R is preferably selected from -D, or a linear alkyl group having 1 to 10 C atoms, or a branched or cyclic alkyl group having 3 to 10 C atoms, or a phenyl group, or a naphthyl group.

[0095] Further, L1 is selected from a single bond or the following groups:

[0096]

[0097] In one embodiment, E1 is selected from a substituted or unsubstituted aromatic group having 6 to 10 ring atoms or a substituted or unsubstituted heteroaromatic group having 5 to 10 ring atoms;

[0098] Furthermore, E1 is selected from the following groups:

[0099]

[0100] Wherein, Y4 is selected from O or S;

[0101] Each occurrence of V is independently selected from N or CR2;

[0102] R2 is independently selected from the group consisting of: -H, -D, straight-chain alkyl with 1 to 20 C atoms, straight-chain alkoxy with 1 to 20 C atoms, straight-chain thioalkoxy with 1 to 20 C atoms, branched or cyclic alkyl with 3 to 20 C atoms, branched or cyclic alkoxy with 3 to 20 C atoms, branched or cyclic thioalkoxy with 3 to 20 C atoms, substituted or unsubstituted silyl, keto with 1 to 20 C atoms, alkoxy with 2 to 20 C atoms, carbonyl, aryloxycarbonyl having 7 to 20 C atoms, cyano, carbamoyl, haloformyl, formyl, isocyano, isocyanate, thiocyanate, isothiocyanate, hydroxyl, nitro, -CF3, -Cl, -Br, -F, substituted or unsubstituted aromatic radical having 6 to 13 ring atoms, substituted or unsubstituted heteroaromatic radical having 5 to 13 ring atoms, substituted or unsubstituted aryloxy radical having 6 to 13 ring atoms, heteroaryloxy radical having 5 to 13 ring atoms, or a combination of these radicals.

[0103] Further, each occurrence of R2 is independently selected from -H, -D, or a straight chain alkyl group having 1 to 10 C atoms, or a branched or cyclic alkyl group having 3 to 10 C atoms, or a phenyl group, or a naphthyl group.

[0104] Further, Ar is selected from the following structures:

[0105]

[0106] In a specific example, Ar1, Ar2, and Ar3 are independently selected from substituted or unsubstituted aromatic groups having 6 to 20 ring atoms, or substituted or unsubstituted heteroaromatic groups having 5 to 20 ring atoms.

[0107] In a specific example, Ar1, Ar2, and Ar3 are independently selected from any one of the groups (C-1) to (C-6):

[0108]

[0109] in:

[0110] Ar5 is selected from a substituted or unsubstituted aromatic group having 6 to 13 ring atoms, a substituted or unsubstituted heteroaromatic group having 6 to 13 ring atoms;

[0111] Each occurrence of X3 is independently selected from N or CR 10 ;

[0112] Y3 is selected from O, S, S=O, SO2, NR 11 , PR 11 , CR 12 R 13or SiR 12 R 13 ;

[0113] R 10 , R 11 , R 12 , R 13 Each occurrence is independently selected from: -H, -D, straight-chain alkyl having 1 to 20 C atoms, straight-chain alkoxy having 1 to 20 C atoms, straight-chain thioalkoxy having 1 to 20 C atoms, branched or cyclic alkyl having 3 to 20 C atoms, branched or cyclic alkoxy having 3 to 20 C atoms, branched or cyclic thioalkoxy having 3 to 20 C atoms, substituted or unsubstituted silyl, keto having 1 to 20 C atoms, alkoxycarbonyl having 2 to 20 C atoms The invention also includes but is not limited to: -C1, -Br, -F, substituted or unsubstituted aromatic groups having 6 to 20 ring atoms, substituted or unsubstituted heteroaromatic groups having 5 to 20 ring atoms, substituted or unsubstituted aryloxy groups having 6 to 20 ring atoms, heteroaryloxy groups having 5 to 20 ring atoms, or combinations of these groups.

[0114] Preferably, Ar5 is selected from X3 and Y3 have the same meanings as described in the general formula.

[0115] In a specific example, (C-3) is selected from the following groups:

[0116]

[0117] In a specific example, Ar1, Ar2, and Ar3 are independently selected from any of the following groups:

[0118]

[0119] The above groups are substituted by R or unsubstituted.

[0120] Specifically, the carbazole compound according to the present invention is selected from the following structures but is not limited thereto:

[0121]

[0122]

[0123]

[0124]

[0125]

[0126] The carbazole organic compound of the present invention can be used as a functional material in the functional layer of an electronic device. The organic functional layer includes, but is not limited to, a hole injection layer (HIL), a hole transport layer (HTL), an electron transport layer (ETL), an electron injection layer (EIL), an electron blocking layer (EBL), a hole blocking layer (HBL), and an emitting layer (EML).

[0127] In a preferred embodiment, the carbazole compound according to the present invention is used as a host material, especially a phosphorescent host material.

[0128] In some embodiments, the carbazole organic compound according to the present invention has a luminescent function, and the luminescent wavelength is between 300 and 1000 nm, preferably between 350 and 900 nm, and more preferably between 400 and 800 nm. The luminescence referred to here refers to photoluminescence or electroluminescence.

[0129] The present invention also relates to a mixture, comprising an organic functional material H1, H1 is selected from the carbazole organic compound as described above, and at least another organic functional material H2. The organic functional material H2 is selected from hole injection material (HIM), hole transport material (HTM), electron transport material (ETM), electron injection material (EIM), electron blocking material (EBM), hole blocking material (HBM), luminophore (Emitter), host material (Host). The luminescent material is selected from singlet luminophore (fluorescent luminophore), triplet luminophore (phosphorescent luminophore), in particular, luminescent organic metal complex and organic thermally excited delayed fluorescence material (TADF material). For example, various organic functional materials are described in detail in WO2010135519A1, US20090134784A1 and WO2011110277A1, and the entire contents of these three patent documents are hereby incorporated herein by reference. The organic functional material can be a small molecule and a polymer material.

[0130] In a preferred embodiment, in the organic mixture, the mass ratio of H1 to H2 is from 2:8 to 8:2; the preferred mass ratio is 3:7 to 7:3; the more preferred mass ratio is 4:6 to 6:4; the most preferred mass ratio is 5:5.

[0131] In a preferred embodiment, the organic mixture, wherein the difference in molecular weight between H1 and H2 is no more than 100 Dalton, preferably no more than 80 Dalton, more preferably no more than 70 Dalton, even better no more than 60 Dalton, very preferably no more than 40 Dalton, and most preferably no more than 30 Dalton.

[0132] In another preferred embodiment, in the organic mixture, the difference in sublimation temperature between H1 and H2 does not exceed 50K; more preferably, the difference in sublimation temperature does not exceed 30K; even more preferably, the difference in sublimation temperature does not exceed 20K; and most preferably, the difference in sublimation temperature does not exceed 10K.

[0133] In a preferred embodiment, according to the organic mixture of the present invention, at least one of H1 and H2 has a glass transition temperature Tg ≥ 100°C, in a preferred embodiment, at least one has a Tg ≥ 120°C, in a more preferred embodiment, at least one has a Tg ≥ 140°C, in a more preferred embodiment, at least one has a Tg ≥ 160°C, and in a most preferred embodiment, at least one has a Tg ≥ 180°C.

[0134] In a more preferred embodiment, the mixture comprises at least one carbazole organic compound according to the present invention and a luminescent material, and the luminescent material is selected from a singlet luminescent body, a triplet luminescent body or a TADF luminescent body.

[0135] In some embodiments, the mixture comprises at least one carbazole organic compound according to the present invention and a singlet light emitter, wherein the weight percentage of the singlet light emitter is ≤10wt%, preferably ≤9wt%, more preferably ≤8wt%, particularly preferably ≤7wt%, and most preferably ≤5wt%.

[0136] In a particularly preferred embodiment, the mixture comprises at least one carbazole organic compound according to the present invention and a triplet light emitter, wherein the weight percentage of the triplet light emitter is ≤25wt%, preferably ≤20wt%, and more preferably ≤15wt%.

[0137] In another preferred embodiment, the mixture comprises at least one carbazole compound according to the present invention, a triplet emitter and a host material. In this embodiment, the compound according to the present invention can be used as an auxiliary luminescent material, and the weight ratio of the compound to the triplet emitter is from 1:2 to 2:1. In another preferred embodiment, the energy level of the exciplex of the mixture according to the present invention is higher than that of the phosphorescent emitter.

[0138] In another more preferred embodiment, the mixture comprises at least one carbazole compound according to the present invention and a TADF material, wherein the weight percentage of the TADF main material is ≤15wt%, preferably ≤10wt%, and more preferably ≤5wt%.

[0139] In a very preferred embodiment, the mixture comprises an organic carbazole compound according to the present invention and another host material. The organic compound according to the present invention can be used as the second host, and its weight percentage can be 30% to 70%.

[0140] For a detailed description of the singlet light emitter, triplet light emitter, TADF material and host material in the present invention, please refer to patent WO2018095390A1.

[0141] In certain preferred embodiments, the mixture, the another organic functional material H2 comprises a structure as shown in general formula (5):

[0142]

[0143] Among them, when R 14 Each occurrence is independently selected from the group consisting of: -H, -D, a linear alkyl group having 1 to 20 C atoms, a linear alkoxy group having 1 to 20 C atoms, a linear thioalkoxy group having 1 to 20 C atoms, a branched or cyclic alkyl group having 3 to 20 C atoms, a branched or cyclic alkoxy group having 3 to 20 C atoms, a branched or cyclic thioalkoxy group having 3 to 20 C atoms, a substituted or unsubstituted silyl group, a keto group having 1 to 20 C atoms, an alkane group having 2 to 20 C atoms, oxycarbonyl, aryloxycarbonyl having 7 to 20 C atoms, cyano, carbamoyl, haloformyl, formyl, isocyano, isocyanate, thiocyanate, isothiocyanate, hydroxy, nitro, -CF3, -Cl, -Br, -F, substituted or unsubstituted aromatic radical having 6 to 20 ring atoms, substituted or unsubstituted heteroaromatic radical having 5 to 20 ring atoms, substituted or unsubstituted aryloxy radical having 6 to 20 ring atoms, heteroaryloxy radical having 5 to 20 ring atoms, or a combination of these radicals;

[0144] Adjacent R 14 can be connected to form a ring; and R 14 At least one of them is selected from structural formula (5-1);

[0145] Ar7, Ar8 are each independently selected from a substituted or unsubstituted aromatic group having 6 to 30 ring atoms, a substituted or unsubstituted heteroaromatic group having 5 to 30 ring atoms, or a substituted or unsubstituted non-aromatic ring group having 5 to 30 ring atoms;

[0146] L2 is selected from a single bond, a substituted or unsubstituted aromatic group having 6 to 30 ring atoms, a substituted or unsubstituted heteroaromatic group having 5 to 30 ring atoms, or a substituted or unsubstituted non-aromatic ring group having 5 to 30 ring atoms;

[0147] Any two of Ar7, Ar8, and L2 can be connected to form a ring.

[0148] Further, H2 is selected from the following general formula:

[0149]

[0150] In one embodiment, Ar8 and L2 are connected to each other to form a ring; further, H2 is selected from the following general formula:

[0151]

[0152] Among them, R 15 Each occurrence is independently selected from -H, -D, straight-chain alkyl having 1 to 20 C atoms, straight-chain alkoxy having 1 to 20 C atoms, straight-chain thioalkoxy having 1 to 20 C atoms, branched or cyclic alkyl having 3 to 20 C atoms, branched or cyclic alkoxy having 3 to 20 C atoms, branched or cyclic thioalkoxy having 3 to 20 C atoms, substituted or unsubstituted silyl, keto having 1 to 20 C atoms, alkoxycarbonyl having 2 to 20 C atoms , aryloxycarbonyl with 7 to 20 C atoms, cyano, carbamoyl, haloformyl, formyl, isocyano, isocyanate, thiocyanate, isothiocyanate, hydroxy, nitro, -CF3, -Cl, -Br, -F, substituted or unsubstituted aromatic groups with 6 to 20 ring atoms, substituted or unsubstituted heteroaromatic groups with 5 to 20 ring atoms, substituted or unsubstituted aryloxy groups with 6 to 20 ring atoms, heteroaryloxy groups with 5 to 20 ring atoms, or combinations of these groups.

[0153] Preferably, the organic functional material H2 is selected from the following structures, but is not limited thereto, wherein H in the structure can be further arbitrarily substituted.

[0154]

[0155]

[0156] An object of the present invention is to provide a material solution for evaporation-type OLEDs.

[0157] In certain embodiments, the compounds according to the present invention have a molecular weight of ≤1200 g / mol, preferably ≤1100 g / mol, very preferably ≤1000 g / mol, more preferably ≤950 g / mol, most preferably ≤900 g / mol.

[0158] Another object of the present invention is to provide a material solution for printed OLEDs.

[0159] In certain embodiments, the compounds according to the present invention have a molecular weight of ≥800 g / mol, preferably ≥900 g / mol, very preferably ≥1000 g / mol, more preferably ≥1100 g / mol, most preferably ≥1200 g / mol.

[0160] In other embodiments, the solubility of the compounds according to the present invention in toluene at 25°C is ≥2 mg / ml, preferably ≥3 mg / ml, more preferably ≥4 mg / ml, and most preferably ≥5 mg / ml.

[0161] The present invention also relates to a composition comprising at least one carbazole organic compound or mixture as described above, and at least one organic solvent; the at least one organic solvent is selected from aromatic or heteroaromatic, ester, aromatic ketone or aromatic ether, aliphatic ketone or aliphatic ether, alicyclic or olefin compounds, or borate or phosphate compounds, or a mixture of two or more solvents.

[0162] In a preferred embodiment, a composition according to the present invention is characterized in that the at least one organic solvent is selected from aromatic or heteroaromatic based solvents.

[0163] Examples of aromatic or heteroaromatic solvents suitable for the present invention include, but are not limited to: p-diisopropylbenzene, pentylbenzene, tetralin, cyclohexylbenzene, chloronaphthalene, 1,4-dimethylnaphthalene, 3-isopropylbiphenyl, p-methylisopropylbenzene, dipentylbenzene, tripentylbenzene, pentyltoluene, o-diethylbenzene, m-diethylbenzene, p-diethylbenzene, 1,2,3,4-tetramethylbenzene, 1,2,3,5-tetramethylbenzene, 1,2,4,5-tetramethylbenzene, butylbenzene, dodecylbenzene, dihexylbenzene, dibutylbenzene, p-diisopropylbenzene, cyclohexylbenzene, benzylbutylbenzene, dimethylnaphthalene, 3-isopropylbiphenyl, p-methylisopropylbenzene, 1-methylnaphthalene, 1,2,4-trichlorobenzene, 4,4-difluorodiphenylmethane, 1,2-dimethoxy-4-(1-propenyl)benzene, diphenylmethane, 2-phenylpyridine, 3-phenylpyridine, N-methyldiphenylamine, 4-isopropylbiphenyl, α, α-dichlorodiphenylmethane, 4-(3-phenylpropyl)pyridine, benzyl benzoate, 1,1-bis(3,4-dimethylphenyl)ethane, 2-isopropylnaphthalene, quinoline, isoquinoline, methyl 2-furoate, ethyl 2-furoate, etc.;

[0164] Examples of aromatic ketone-based solvents suitable for the present invention include, but are not limited to: 1-tetralone, 2-tetralone, 2-(phenylepoxy)tetralone, 6-(methoxy)tetralone, acetophenone, propiophenone, benzophenone, and their derivatives, such as 4-methylacetophenone, 3-methylacetophenone, 2-methylacetophenone, 4-methylpropiophenone, 3-methylpropiophenone, 2-methylpropiophenone, etc.;

[0165] Examples of aromatic ether-based solvents suitable for the present invention include, but are not limited to: 3-phenoxytoluene, butoxybenzene, p-anisaldehyde dimethyl acetal, tetrahydro-2-phenoxy-2H-pyran, 1,2-dimethoxy-4-(1-propenyl)benzene, 1,4-benzodioxane, 1,3-dipropylbenzene, 2,5-dimethoxytoluene, 4-ethyl ethyl ether, 1,3-dipropoxybenzene, 1,2,4-trimethoxybenzene, 4-(1-propenyl)-1,2-dimethoxybenzene, 1,3-dimethoxybenzene, glycidyl phenyl ether, dibenzyl ether, 4-tert-butylanisole, trans-p-propenylanisole, 1,2-dimethoxybenzene, 1-methoxynaphthalene, diphenyl ether, 2-phenoxymethyl ether, 2-phenoxytetrahydrofuran, ethyl-2-naphthyl ether;

[0166] In some preferred embodiments, according to the composition of the present invention, the at least one solvent can be selected from: aliphatic ketones, for example, 2-nonanone, 3-nonanone, 5-nonanone, 2-decanone, 2,5-hexanedione, 2,6,8-trimethyl-4-nonanone, fenchone, phorone, isophorone, di-n-amyl ketone, etc.; or aliphatic ethers, for example, amyl ether, hexyl ether, dioctyl ether, ethylene glycol dibutyl ether, diethylene glycol diethyl ether, diethylene glycol butyl methyl ether, diethylene glycol dibutyl ether, triethylene glycol dimethyl ether, triethylene glycol ethyl methyl ether, triethylene glycol butyl methyl ether, tripropylene glycol dimethyl ether, tetraethylene glycol dimethyl ether, etc.

[0167] In other preferred embodiments, according to the composition of the present invention, the at least one solvent can be selected from ester-based solvents: alkyl octanoate, alkyl sebacate, alkyl stearate, alkyl benzoate, alkyl phenylacetate, alkyl cinnamate, alkyl oxalate, alkyl maleate, alkyl lactone, alkyl oleate, etc. Octyl octanoate, diethyl sebacate, diallyl phthalate, isononyl isononanoate, etc. are particularly preferred.

[0168] The solvent may be used alone or as a mixture of two or more organic solvents.

[0169] In certain preferred embodiments, a composition according to the present invention is characterized in that it comprises at least one organic compound or polymer or mixture as described above and at least one organic solvent, and may further comprise another organic solvent. Examples of another organic solvent include (but are not limited to): methanol, ethanol, 2-methoxyethanol, dichloromethane, chloroform, chlorobenzene, o-dichlorobenzene, tetrahydrofuran, anisole, morpholine, toluene, o-xylene, m-xylene, p-xylene, 1,4-dioxane, acetone, methyl ethyl ketone, 1,2-dichloroethane, 3-phenoxytoluene, 1,1,1-trichloroethane, 1,1,2,2-tetrachloroethane, ethyl acetate, butyl acetate, dimethylformamide, dimethylacetamide, dimethyl sulfoxide, tetralin, decalin, indene and / or mixtures thereof.

[0170] In some preferred embodiments, the solvents particularly suitable for the present invention are solvents having a Hansen solubility parameter within the following ranges:

[0171] δ d (Dispersion force) 17.0~23.2MPa 1 / 2 range, especially in the range of 18.5~21.0MPa 1 / 2 scope;

[0172] δ p (Polar force) 0.2~12.5MPa 1 / 2 range, especially in the range of 2.0~6.0MPa 1 / 2 scope;

[0173] δ h (Hydrogen bond force) 0.9~14.2MPa 1 / 2 range, especially in the range of 2.0~6.0MPa 1 / 2 range.

[0174] According to the composition of the present invention, the organic solvent should be selected considering its boiling point parameter. In the present invention, the boiling point of the organic solvent is ≥150°C; preferably ≥180°C; more preferably ≥200°C; more preferably ≥250°C; most preferably ≥275°C or ≥300°C. Boiling points within these ranges are beneficial for preventing nozzle clogging of the inkjet print head. The organic solvent can be evaporated from the solvent system to form a film containing a functional material.

[0175] In a preferred embodiment, the composition according to the invention is a solution.

[0176] In another preferred embodiment, the composition according to the invention is a suspension.

[0177] The composition in the embodiment of the present invention may include 0.01 to 10 wt % of the carbazole organic compound or mixture according to the present invention, preferably 0.1 to 15 wt %, more preferably 0.2 to 5 wt %, and most preferably 0.25 to 3 wt %.

[0178] The present invention also relates to the use of the composition as a coating or printing ink in the preparation of organic electronic devices, and particularly preferably a preparation method by printing or coating.

[0179] Among them, suitable printing or coating techniques include (but are not limited to) inkjet printing, nozzle printing, letterpress printing, screen printing, dip coating, spin coating, doctor blade coating, roller printing, twist roller printing, lithography, flexographic printing, rotary printing, spraying, brushing or pad printing, slot extrusion coating, etc. The preferred ones are gravure printing, nozzle printing and inkjet printing. The solution or suspension may further include one or more components such as surfactant compounds, lubricants, wetting agents, dispersants, hydrophobic agents, adhesives, etc., for adjusting viscosity, film-forming properties, improving adhesion, etc.

[0180] The present invention also provides an application of the above-mentioned carbazole organic compound, mixture or composition in an organic electronic device. The technical solution is as follows:

[0181] An organic electronic device comprises at least one of the above-mentioned carbazole organic compounds, a mixture or a composition thereof. Generally, the organic electronic device comprises at least one cathode, one anode and one or more functional layers between the cathode and the anode, wherein the at least one functional layer comprises one of the above-mentioned compounds, a mixture or a composition thereof.

[0182] The organic electronic device can be selected from, but not limited to, organic light emitting diodes (OLED), organic photovoltaic cells (OPV), organic light emitting cells (OLEEC), organic field effect transistors (OFET), organic light emitting field effect transistors, organic lasers, organic spin electronic devices, organic sensors and organic plasmon emitting diodes (Organic Plasmon Emitting Diode), etc., and organic electroluminescent devices such as OLED, OLEEC, and organic light emitting field effect transistors are particularly preferred.

[0183] In certain preferred embodiments, the organic electronic device comprises a light-emitting layer, and the light-emitting layer comprises a carbazole organic compound or a mixture as described above or is prepared from the above composition.

[0184] In certain preferred embodiments, the organic electronic device, the light-emitting layer of which contains a compound as described above, or contains a compound as described above and a phosphorescent light-emitting material, or contains a carbazole organic compound as described above and a host material, or contains a compound as described above and a TADF material.

[0185] In certain preferred embodiments, the light-emitting layer of the organic electronic device comprises a carbazole organic compound as described in formula (1) and an organic compound as described in formula (5).

[0186] The light emitting device described above, especially OLED, comprises a substrate, an anode, at least one light emitting layer, and a cathode.

[0187] The substrate can be opaque or transparent. A transparent substrate can be used to make a transparent light-emitting device. The substrate can be rigid or elastic. The substrate can be plastic, metal, semiconductor wafer or glass. It is best if the substrate has a smooth surface. Substrates without surface defects are particularly ideal. In a preferred embodiment, the substrate is flexible and can be selected from polymer films or plastics, and its glass transition temperature Tg is above 150°C, preferably above 200°C, more preferably above 250°C, and most preferably above 300°C. Examples of suitable flexible substrates are poly(ethylene terephthalate) (PET) and polyethylene glycol (2,6-naphthalene) (PEN).

[0188] The anode may include a conductive metal or metal oxide, or a conductive polymer. The anode can easily inject holes into the hole injection layer (HIL) or the hole transport layer (HTL) or the light-emitting layer. In one embodiment, the absolute value of the difference between the work function of the anode and the HOMO energy level or valence band energy level of the light-emitting body in the light-emitting layer or the p-type semiconductor material as the HIL or HTL or the electron blocking layer (EBL) is less than 0.5 eV, preferably less than 0.3 eV, and most preferably less than 0.2 eV. Examples of anode materials include, but are not limited to: Al, Cu, Au, Ag, Mg, Fe, Co, Ni, Mn, Pd, Pt, ITO, aluminum-doped zinc oxide (AZO), etc. Other suitable anode materials are known and can be easily selected for use by a person of ordinary skill in the art. The anode material can be deposited using any suitable technique, such as a suitable physical vapor deposition method, including radio frequency magnetron sputtering, vacuum thermal evaporation, electron beam (e-beam), etc. In some embodiments, the anode is patterned. Patterned ITO conductive substrates are commercially available and can be used to prepare devices according to the present invention.

[0189] The cathode may include a conductive metal or metal oxide. The cathode can easily inject electrons into the EIL or ETL or directly into the light-emitting layer. In one embodiment, the absolute value of the difference between the work function of the cathode and the LUMO energy level or conduction band energy level of the luminophore in the light-emitting layer or the n-type semiconductor material as the electron injection layer (EIL) or the electron transport layer (ETL) or the hole blocking layer (HBL) is less than 0.5 eV, preferably less than 0.3 eV, and most preferably less than 0.2 eV. In principle, all materials that can be used as cathodes of OLEDs may be used as cathode materials for the device of the present invention. Examples of cathode materials include, but are not limited to, Al, Au, Ag, Ca, Ba, Mg, LiF / Al, MgAg alloy, BaF2 / Al, Cu, Fe, Co, Ni, Mn, Pd, Pt, ITO, etc. The cathode material can be deposited using any suitable technique, such as a suitable physical vapor deposition method, including radio frequency magnetron sputtering, vacuum thermal evaporation, electron beam (e-beam), etc.

[0190] OLEDs may also include other functional layers, such as a hole injection layer (HIL), a hole transport layer (HTL), an electron blocking layer (EBL), an electron injection layer (EIL), an electron transport layer (ETL), and a hole blocking layer (HBL). Materials suitable for use in these functional layers are described in detail above and in WO2010135519A1, US20090134784A1, and WO2011110277A1, and the entire contents of these three patent documents are hereby incorporated herein by reference.

[0191] According to the light emitting device of the present invention, the light emission wavelength is between 300 and 1200 nm, preferably between 350 and 1000 nm, and more preferably between 400 and 900 nm.

[0192] The present invention also relates to the application of the electroluminescent device according to the present invention in various electronic devices, including, but not limited to, display devices, lighting devices, light sources, sensors and the like.

[0193] The present invention will be described below in conjunction with preferred embodiments, but the present invention is not limited to the following embodiments. It should be understood that the attached claims summarize the scope of the present invention. Under the guidance of the concept of the present invention, those skilled in the art should be aware that certain changes made to the various embodiments of the present invention will be covered by the spirit and scope of the claims of the present invention. Specific embodiments

[0195] The carbazole compounds and the preparation method of the present invention are further described in detail below in conjunction with specific examples. The raw materials used in the following examples are all commercially available products unless otherwise specified.

[0196] Example 1

[0197] This embodiment provides a carbazole compound, and the specific synthesis route is as follows:

[0198]

[0199] Synthesis of intermediate 1-2: 1-1 (60 mmol), bipyralidin (60 mmol), Pd(dppf)Cl2 (0.2 mmol) and potassium acetate (70 mmol) were added to 180 ml of 1,4-dioxane and stirred at 100 ° C for 5 h in a nitrogen environment. After cooling, the solvent was removed by rotary evaporation, the residue was dissolved in dichloromethane and the liquid was washed with water, and the organic phase was collected. After the organic phase was rotary evaporated to remove the solvent, the obtained crude product was recrystallized to obtain intermediate 1-2 with a yield of 75%.

[0200] Synthesis of intermediate 1-4: Intermediate 1-2 (42 mmol) and intermediate 1-3 (42 mmol) were dissolved in a mixed solvent of 1,4-dioxane and water (200 / 20 ml), and Pd(PPh3)4 (0.5 mmol) and potassium carbonate (75 mmol) were added. Stir at 100 ° C for 6 h under nitrogen environment. After cooling, most of the solvent was removed by rotary evaporation, and then the product was extracted with dichloromethane and washed with water. The organic phase was collected and the solvent was removed by rotary evaporation. The crude product was purified by column chromatography to obtain intermediate 1-4 with a yield of 90%.

[0201] Synthesis of compound 1: Intermediate 1-4 (30 mmol), intermediate 1-5 (30 mmol), Pd(dba)2 (0.3 mmol), tri-tert-butylphosphine (0.6 mmol) and sodium tert-butoxide (40 mmol) were dissolved in toluene and stirred at 100°C for 12 h under nitrogen. After cooling, water was added to the reaction solution, washed with water and separated, the organic phase was collected, and the solvent was removed by rotary evaporation. The crude product was purified by column chromatography and recrystallization to obtain compound 1 with a yield of 80%. MS (ASAP): 626.

[0202] Example 2

[0203] This embodiment provides a carbazole compound, and the specific synthesis route is as follows:

[0204]

[0205] Synthesis of compound 2: 1-4 (15 mmol) and 2-1 (15 mmol) were dissolved in 100 ml of dry toluene, and Pd2(dba)3 (0.1 mmol), tri-tert-butylphosphine (0.2 mmol) and sodium tert-butoxide (20 mmol) were added, and refluxed at 100°C for 6 h. After cooling, water was added to the reaction solution, washed with water and separated, and the organic phase was collected. After the organic phase was evaporated to remove the solvent, the obtained crude product was purified by column chromatography and recrystallization to obtain compound 2. MS (ASAP): 626.

[0206] Example 3

[0207] This embodiment provides a carbazole compound, and the specific synthesis route is as follows:

[0208]

[0209] Synthesis of intermediate 3-3: Dissolve intermediate 3-1 (50 mmol) and intermediate 3-2 (50 mmol) in a mixed solvent of 1,4-dioxane and water (200 / 20 ml), and add Pd(PPh3)4 (0.5 mmol) and sodium carbonate (80 mmol). Stir at 80°C for 4 h under nitrogen. After cooling, add a large amount of water to the reaction solution and filter to collect the filter cake. The crude product is purified by column chromatography to obtain intermediate 3-3 with a yield of 80%.

[0210] Synthesis of intermediate 3-5: Intermediate 3-3 (40 mmol) and intermediate 3-4 (40 mmol) were dissolved in a mixed solvent of 1,4-dioxane and water (200 / 20 ml), and Pd(PPh3)4 (0.5 mmol) and potassium carbonate (75 mmol) were added. Stir at 80°C for 4 h under nitrogen. After cooling, most of the solvent was removed by rotary evaporation, and then the product was extracted with dichloromethane and washed with water. The organic phase was collected and the solvent was removed by rotary evaporation. The crude product was purified by column chromatography to obtain intermediate 3-5 with a yield of 90%.

[0211] Synthesis of compound 3: Intermediate 3-5 (30 mmol), intermediate 1-4 (30 mmol), Pd(dba)2 (0.3 mmol), tri-tert-butylphosphine (0.6 mmol) and sodium tert-butoxide (40 mmol) were dissolved in toluene and stirred at 100°C for 12 h under nitrogen. After cooling, the mixture was washed with water and separated. The organic phase was collected and the solvent was removed by rotary evaporation. The crude product was purified by column chromatography and recrystallization to obtain compound 3 with a yield of 78%. MS (ASAP): 676.

[0212] Example 4

[0213] This embodiment provides a carbazole compound, and the specific synthesis route is as follows:

[0214]

[0215] Synthesis of intermediate 4-2: Intermediate 4-1 (40 mmol) and intermediate 3-4 (40 mmol) were dissolved in a mixed solvent of 1,4-dioxane and water (200 / 20 ml), and Pd(PPh3)4 (0.5 mmol) and potassium carbonate (75 mmol) were added. Stir at 80 ° C for 4 h under nitrogen environment. After cooling, most of the solvent was removed by rotary evaporation, and then the product was extracted with dichloromethane and washed with water. The organic phase was collected and the solvent was removed by rotary evaporation. The crude product was purified by column chromatography to obtain intermediate 4-2 with a yield of 92%.

[0216] The synthesis of compound 4 was based on the synthesis of compound 3, except that 3-5 was replaced by 4-2, with a yield of 76%. MS (ASAP): 599.

[0217] Example 5

[0218] This embodiment provides a carbazole compound, and the specific synthesis route is as follows:

[0219]

[0220] The synthesis of intermediate 5-3 refers to the synthesis of 4-2, except that 4-1 is replaced by 5-1, and 3-4 is replaced by 5-2, with a yield of 75%.

[0221] The synthesis of intermediate 5-5 refers to the synthesis of 1-4, except that 1-3 is replaced by 5-4, and the yield is 85%.

[0222] The synthesis of compound 5 was based on the synthesis of compound 3, except that 1-4 was replaced by 5-5, and 3-5 was replaced by 5-3, with a yield of 76%. MS (ASAP): 700.

[0223] Example 6

[0224] This embodiment provides a carbazole compound, and the specific synthesis route is as follows:

[0225]

[0226] The synthesis of intermediate 6-2 was based on the synthesis of intermediate 1-4, except that 1-3 was replaced by 6-1. The yield was 85%.

[0227] The synthesis of compound 6 was based on the synthesis of compound 1, except that 1-4 was replaced by 6-2, with a yield of 75%. MS (ASAP): 732.

[0228] Example 7

[0229] This embodiment provides a carbazole compound, and the specific synthesis route is as follows:

[0230]

[0231] The synthesis of intermediate 7-3 refers to the synthesis of intermediate 3-5, except that 3-3 is replaced by 7-1, and 3-4 is replaced by 7-2, with a yield of 80%.

[0232] The synthesis of intermediate 7-5 refers to the synthesis of intermediate 1-4, except that 1-3 is replaced by 7-4, and the yield is 90%.

[0233] The synthesis of compound 7 was based on the synthesis of compound 3, except that 1-4 was replaced by 7-5, and 3-5 was replaced by 7-3, with a yield of 80%. MS (ASAP): 676.

[0234] Example 8

[0235] This embodiment provides a carbazole compound, and the specific synthesis route is as follows:

[0236]

[0237] The synthesis of intermediate 8-2 refers to the synthesis of 4-2, except that 3-4 is replaced by 8-1, and the yield is 85%.

[0238] The synthesis of compound 8 was based on the synthesis of compound 3, except that 1-4 was replaced by 7-5, and 3-5 was replaced by 8-2, with a yield of 82%. MS (ASAP): 705.

[0239] Example 9

[0240] This embodiment provides a carbazole compound, and the specific synthesis route is as follows:

[0241]

[0242] The synthesis of intermediate 9-2 refers to the synthesis of 1-4, except that 1-3 is replaced by 9-1, and the yield is 85%.

[0243] The synthesis of compound 9 was based on the synthesis of compound 2, except that 1-4 was replaced by 9-2, and 2-1 was replaced by 9-3, with a yield of 84%. MS (ASAP): 649.

[0244] Example 10

[0245] This embodiment provides a carbazole compound, and the specific synthesis route is as follows:

[0246]

[0247] The synthesis of intermediate 10-2 was based on the synthesis of 1-4, except that 1-3 was replaced by 10-1, with a yield of 82%.

[0248] The synthesis of compound 10 was based on the synthesis of compound 3, except that 1-4 was replaced by 10-2, and 3-5 was replaced by 4-2, with a yield of 83%. MS (ASAP): 689.

[0249] Embodiment 11

[0250] This embodiment provides a carbazole compound, and the specific synthesis route is as follows:

[0251]

[0252] The synthesis of intermediate 11-2 refers to the synthesis of 1-4, except that 1-3 is replaced by 11-1, and the yield is 95%.

[0253] The synthesis of compound 11 was based on the synthesis of compound 1, except that 1-4 was replaced by 11-2, and 1-5 was replaced by 11-3, with a yield of 90%. MS (ASAP): 702.

[0254] Example 12

[0255] This embodiment provides a carbazole compound, and the specific synthesis route is as follows:

[0256]

[0257] The synthesis of intermediate 12-2 refers to the synthesis of 1-4, except that 1-3 is replaced by 12-1, and the yield is 90%.

[0258] The synthesis of compound 12 was based on the synthesis of compound 3, except that 1-4 was replaced by 12-2, and 3-5 was replaced by 4-2, with a yield of 85%. MS (ASAP): 699.

[0259] Embodiment 13

[0260] This embodiment provides a carbazole compound, and the specific synthesis route is as follows:

[0261]

[0262] The synthesis of intermediate 13-2 refers to the synthesis of 1-4, except that 1-3 is replaced by 13-1, and the yield is 90%.

[0263] The synthesis of compound 13 was based on the synthesis of compound 1, except that 1-4 was replaced by 13-2, with a yield of 87%. MS (ASAP): 626.

[0264] Embodiment 14

[0265] This embodiment provides a carbazole compound, and the specific synthesis route is as follows:

[0266]

[0267] The synthesis of intermediate 14-2 refers to the synthesis of 3-3, except that 3-2 is replaced by 14-1, and the yield is 75%.

[0268] The synthesis of compound 14-3 was based on the synthesis of 3-5, except that 3-3 was replaced by 14-2, with a yield of 80%.

[0269] The synthesis of compound 14 was based on the synthesis of compound 3, except that 3-5 was replaced by 14-3, with a yield of 76%. MS (ASAP): 792.

[0270] Embodiment 15

[0271] This embodiment provides a carbazole compound, and the specific synthesis route is as follows:

[0272]

[0273] The synthesis of intermediate 15-3 refers to the synthesis of 3-3, except that 3-1 is replaced by 15-1, and 3-2 is replaced by 15-2, with a yield of 72%.

[0274] The synthesis of intermediate 15-4 was based on the synthesis of 3-5, except that 3-3 was replaced by 15-3, with a yield of 82%.

[0275] The synthesis of compound 15 was based on the synthesis of compound 3, except that 3-5 was replaced by 15-4, with a yield of 75%. MS (ASAP): 741.

[0276] Example 16

[0277] This embodiment provides a carbazole compound, and the specific synthesis route is as follows:

[0278]

[0279] The synthesis of intermediate 16-2 refers to the synthesis of 1-4, except that 1-3 is replaced by 16-1, and the yield is 85%.

[0280] The synthesis of intermediate 16-4 was based on the synthesis of 3-3, except that 3-1 was replaced by 15-1, and 3-2 was replaced by 16-3, with a yield of 70%.

[0281] The synthesis of intermediate 16-5 refers to the synthesis of 3-5, except that 3-3 is replaced by 16-4, with a yield of 84%.

[0282] The synthesis of compound 16 was based on the synthesis of compound 3, except that 3-5 was replaced by 16-5, and 1-4 was replaced by 16-2, with a yield of 72%. MS (ASAP): 840.

[0283] Embodiment 17

[0284] This embodiment provides a carbazole compound, and the specific synthesis route is as follows:

[0285]

[0286] The synthesis of intermediate 17-2 was based on the synthesis of intermediate 1-4, except that 1-3 was replaced by 17-1, with a yield of 72%.

[0287] The synthesis of compound 17 was based on the synthesis of compound 3, except that 1-4 was replaced by 17-2, and 3-5 was replaced by 4-2, with a yield of 70%. MS (ASAP): 699.

[0288] Embodiment 18

[0289]

[0290] The synthesis of compound 18 was based on the synthesis of compound 1, except that 1-5 was replaced by 18-1, with a yield of 75%. MS (ASAP): 599.

[0291] Embodiment 19

[0292] This embodiment provides a carbazole compound, and the specific synthesis route is as follows:

[0293]

[0294] The synthesis of compound 19 was based on the synthesis of compound 1, except that 1-5 was replaced by 19-1, with a yield of 85%. MS (ASAP): 655.

[0295] Embodiment 20

[0296] This embodiment provides a carbazole compound, and the specific synthesis route is as follows:

[0297]

[0298] The synthesis of compound 20 was based on the synthesis of compound 1, except that 1-5 was replaced by 20-1, with a yield of 84%. MS (ASAP): 649.

[0299] Embodiment 21

[0300] This embodiment provides a carbazole compound, and the specific synthesis route is as follows:

[0301]

[0302] The synthesis of compound 21 was based on the synthesis of compound 1, except that 1-5 was replaced by 21-1, with a yield of 85%. MS (ASAP): 639.

[0303] Device Example 1

[0304] The device structure is ITO / HATCN / HTM / host material (compound 1): RD / ETM: Liq / Liq / Al. The mass ratio of the host material to RD is 95:5. The specific preparation process is as follows:

[0305] a. Cleaning of the conductive glass substrate: When used for the first time, it can be cleaned with a variety of solvents, such as chloroform, ketone, isopropanol, and then treated with ultraviolet ozone plasma;

[0306] b. HATCN (30nm), HTM (50nm), main material: RD (40nm), ETM: Liq (30nm), Liq (1nm), Al (100nm) in high vacuum (1×10 -6 mbar) by medium heat evaporation;

[0307] c. Packaging: The device is encapsulated with UV-curable resin in a nitrogen glove box.

[0308]

[0309]

[0310] The preparation of the OLED device refers to the device example 1, except that the host material is replaced with the host material shown in Table 1, wherein the mixture is blended at a mass ratio of 1:1.

[0311] Table 1

[0312]

[0313]

[0314] The current-voltage (JV) characteristics of each OLED device are characterized by a characterization device, and important parameters such as efficiency, lifetime and external quantum efficiency are recorded at the same time. Table 1 is a comparison of the lifetime and external quantum efficiency of OLED devices, where the lifetime LT95 is the time when the brightness drops to 95% of the initial brightness @1000nits under constant current. Here, LT95 and external quantum efficiency are calculated relative to device comparative example 1 (corresponding to comparative example 1), that is, the lifetime of device comparative example 1 is 1 and the external quantum efficiency is 100%.

[0315] The device external quantum efficiency and lifetime of device examples 1 to 21 are significantly higher than those of device comparative example 1 (corresponding to comparative example 1) and device comparative example 2 (corresponding to comparative example 2). The device external quantum efficiency and lifetime of device examples 22 to 25 are higher than those of device comparative example 5 (corresponding to comparative example 1: H2-1) and device comparative example 6 (corresponding to comparative example 2: H2-1).

[0316] The device lifespans of device examples 22 to 25 are significantly longer than those of device examples 1, 2, 5, and 12, indicating that the efficiency and lifespan of the device using the mixture of the present invention as a co-host are higher than those of the corresponding single-host device examples. It can be seen that the OLED device prepared using the organic matter and the mixture of the present invention has significantly improved luminous efficiency and lifespan.

[0317] The technical features of the above-described embodiments may be arbitrarily combined. To make the description concise, not all possible combinations of the technical features in the above-described embodiments are described. However, as long as there is no contradiction in the combination of these technical features, they should be considered to be within the scope of this specification.

[0318] The above-described embodiments only express several implementation methods of the present invention, which are convenient for understanding the technical solutions of the present invention in detail, but they cannot be understood as limiting the scope of protection of the invention patent. It should be pointed out that, for ordinary technicians in this field, several variations and improvements can be made without departing from the concept of the present invention, which all belong to the protection scope of the present invention. It should be understood that the technical solutions obtained by those skilled in the art through logical analysis, reasoning or limited experiments on the basis of the technical solutions provided by the present invention are all within the protection scope of the claims attached to the present invention. Therefore, the protection scope of the patent of the present invention shall be based on the contents of the attached claims, and the description can be used to interpret the contents of the claims.

Claims

1. A carbazole compound, characterized in that: Its structure is shown in the general formula (1): in: A is selected from any one of the following groups: X1, at each occurrence, is selected from CR3, R3 is selected from H or D; Y1 is selected from O or S; L1 is selected from a single bond or any one of the groups shown in the following formula: Y2 is selected from O or S; Ar is selected from any one of the groups shown in the following formula: Y4 is selected from S or O; Ar1, Ar2, Ar3 are selected from one of the groups shown in the following formula: Y3 is selected from NR 11 , CR 12 R 13 ; R 11 Selected from phenyl, R 12 , R 13 Selected from methyl; * indicates a fusion site or a linking site.

2. The carbazole compound according to claim 1, characterized in that The structure of the carbazole compound is selected from any one of the structures shown in general formulas (3-1) to (3-16):

3. The carbazole compound according to claim 1, characterized in that The carbazole compound is selected from the following structures:

4. A mixture, characterized in that The mixture comprises the carbazole compound according to any one of claims 1 to 3, and at least one organic functional material, wherein the organic functional material is selected from hole injection materials, hole transport materials, electron transport materials, electron injection materials, electron blocking materials, hole blocking materials, luminophores or host materials.

5. A composition, characterized in that The composition comprises the carbazole compound according to any one of claims 1 to 3 or the mixture according to claim 4, and at least one organic solvent.

6. An organic electronic device, characterized in that: The organic electronic device comprises the carbazole compound according to any one of claims 1 to 3, the mixture according to claim 4 or a functional layer prepared from the composition according to claim 5.

Citation Information

Patent Citations

  • Carbazole-containing materials in phosphorescent light emitting diodes

    US20090134784A1

  • Metal complexes with boron-nitrogen heterocycle containing ligands for use in organic light emitting devices

    WO2010135519A1

  • Fibers in therapy and cosmetics

    WO2011110277A1

  • Organic compound, applications thereof, organic mixture, and organic electronic device

    WO2018095390A1

  • Novel compounds for organic electronic material and organic electronic device using the same

    CN102203212A